| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/01/2008 | US7351811 Gene SCC-112 and diagnostic and therapeutic uses thereof |
| 04/01/2008 | US7351810 Polypeptides, polynucleotides and uses thereof |
| 04/01/2008 | US7351807 Cyanine-sulfenates for dual phototherapy |
| 04/01/2008 | US7351804 Antibodies against PRO4421 |
| 04/01/2008 | US7351802 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis |
| 04/01/2008 | US7351801 Using cation exchange on a bimodal high salt tolerant matrix to isolate/recover human serum albumin from cell culture supernatant |
| 04/01/2008 | US7351799 Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays |
| 04/01/2008 | US7351798 Stabilized protein crystals, formulations comprising them and methods of making them |
| 04/01/2008 | US7351797 Labeled peptides, and processes and intermediates useful for their preparation |
| 04/01/2008 | US7351796 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 04/01/2008 | US7351795 PRO19563 polypeptides |
| 04/01/2008 | US7351794 PRO1754 polypeptides |
| 04/01/2008 | US7351793 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 04/01/2008 | US7351792 G-protein coupled receptor for use as tool in identify modulators which prevent serine protease activation in response to trauma and immune system attack |
| 04/01/2008 | US7351790 Peptide-based compounds |
| 04/01/2008 | US7351789 For pharmaceuticals, diagnostics, biosensors and bioreactors |
| 04/01/2008 | US7351694 Diagnosis of prostate cancer; genetic engineered protein |
| 04/01/2008 | US7351693 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 04/01/2008 | US7351688 Compositions and methods for less immunogenic protein formulations |
| 04/01/2008 | US7351687 Peptide structure containing lanthionine and methyllanthionine as constituents isolated from Microbispora sp. ATCC PTA-5024; methicillin resistant and vancomycin resistant bacteria; M. catharralis, Neisseria species and H. influenzae and Mycobacteria |
| 04/01/2008 | US7351583 Antibodies to G protein-coupled receptor |
| 04/01/2008 | US7351578 Microarray comprising two or more immobilized vectors for use as replication and gene transfer tools; simultaneous cloning of two or more nucleotide sequences |
| 04/01/2008 | US7351577 For hemophilia gene therapy |
| 04/01/2008 | US7351570 Hepatitis d viral nucleotide sequences for use in diagnosis of hepatitis b infection |
| 04/01/2008 | US7351555 Expression vector comprising nucleotide sequences coding cytokine receptor (Zcytor16) for use as antagonist tool of interleukin-10 related t-cell derived inducible factor in diagnosis, treatment and prevention of cell proliferative and inflammatory disorders |
| 04/01/2008 | US7351553 BK beta subunits of Slo family potassium channels |
| 04/01/2008 | US7351552 Modified pro-α peptides and their uses |
| 04/01/2008 | US7351551 Adipocyte differentiation-associated gene and protein |
| 04/01/2008 | US7351550 Exoenzyme toxin of Aeromonas salmonicida, and uses thereof |
| 04/01/2008 | US7351545 Pre-treating breast cancer cells with an IGFBP-3 fragment or fusion protein that binds IGF-I or IGF-II for 24 hours prior to treating the cells with an apoptotic factor( paclitaxel, doxorubicin) and native-sequence human IGFBP-3 or fragment or fusion protein for determining enhancement of apoptosis |
| 04/01/2008 | US7351543 Antibodies to a polypeptide encoded by a nucleic acid underexpressed in melanoma |
| 04/01/2008 | US7351537 Variants of cyan fluorescent protein with improved fluorescent properties |
| 04/01/2008 | US7351535 Using cholesterol transport protein to identify modulators which enhance high density lipoprotein concentration in blood |
| 04/01/2008 | US7351533 Recombinant papilloma virions capable of forming conformational antigenic epitopes for use as therapeutic delivery systems; viricides; antitumor agents |
| 04/01/2008 | US7351435 Detoxification of ricin by complexing with antibodies |
| 04/01/2008 | US7351416 Administering to mammals, poultry; immunization; prevent sepsis, hemorrage, pneumonia, cholera; isolated Pasteurella; attenuation bacteria |
| 04/01/2008 | US7351414 Administering parathyroid hormone; crystal proteins; for treatment of osteoporosis |
| 04/01/2008 | US7351413 Stabilized HBc chimer particles as immunogens for chronic hepatitis |
| 04/01/2008 | US7351411 Administering a VEGF antagonist comprising a fusion polypeptide having an immunoglobulin-like (Ig) domain 2 of the VEGF receptor Flt1 and Ig domain 3 of the VEGF receptor Flk1 or Flt4, and a multimerizing component |
| 04/01/2008 | US7351409 Tumor antigens and CTL clones isolated by a novel procedure |
| 04/01/2008 | CA2408223C Plant brassinolide responsive genes and use thereof |
| 04/01/2008 | CA2341240C Autoantibody inhibitors |
| 04/01/2008 | CA2305623C Porcine circovirus, vaccines, and diagnostic reagents |
| 04/01/2008 | CA2217173C Isolation of a cdna clone encoding a subunit of the alternaria alternata major allergen alt a 1, and production of recombinant protein thereof |
| 04/01/2008 | CA2175992C In situ modification and manipulation of stem cells of the central nervous system |
| 03/27/2008 | WO2008036838A2 Isolated complexes of covalently cross-linked endotoxin and modified md-2 |
| 03/27/2008 | WO2008036761A2 Anti-microbial defensin-related peptides and methods of use |
| 03/27/2008 | WO2008036393A1 Collagen preparation and method of isolation |
| 03/27/2008 | WO2008036135A2 Crystal structure of crig and c3b: crig complex |
| 03/27/2008 | WO2008035350A1 Antigen specific multi epitope vaccines |
| 03/27/2008 | WO2008035024A1 Ccn3 peptide |
| 03/27/2008 | WO2008034881A1 Protease resistant insulin analogues |
| 03/27/2008 | WO2008034648A1 Process for the production of a fine chemical |
| 03/27/2008 | WO2008034608A1 The death receptor cd95 controls neurogenesis of adult neural stem cells in vivo and in vitro |
| 03/27/2008 | WO2008034388A1 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof |
| 03/27/2008 | WO2008034297A1 Method of detecting antibodies against a series of human immunodeficiency virus proteins |
| 03/27/2008 | WO2008034161A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses therefor |
| 03/27/2008 | WO2008015436A3 Diabetes test |
| 03/27/2008 | WO2008015273A8 Cd4-receptor-derived peptides and method for the preparation thereof |
| 03/27/2008 | WO2008011519A3 Amigo-2 inhibitors for treating, diagnosing or detecting cancer |
| 03/27/2008 | WO2008005621A3 Compositions and methods for modulating immune responses |
| 03/27/2008 | WO2008003473A3 Compositions and methods for enhancing the efficacy of il-2 mediated immune responses |
| 03/27/2008 | WO2008001126A3 Compositions and methods relating to cellular targeting |
| 03/27/2008 | WO2008000516A3 IMPROVED sgp130Fc DIMERS |
| 03/27/2008 | WO2007149550A3 Modulation of differentiation and cell function via fox01 and notch signaling |
| 03/27/2008 | WO2007122400A3 Novel polypeptides and use thereof |
| 03/27/2008 | WO2007121462A3 CRYSTAL STRUCTURE OF LXR-ß AND LXR-α |
| 03/27/2008 | WO2007119576A9 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family |
| 03/27/2008 | WO2007118790A3 Active potassium channel transporters (akt) and their use to create stress tolerant plants |
| 03/27/2008 | WO2007115837B1 Combination of an anti-edb fibronectin domain antibody/ il2 fusion protein and a further small molecule |
| 03/27/2008 | WO2007105111A3 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 03/27/2008 | WO2007038829A8 Method of drug design |
| 03/27/2008 | WO2006056480A3 Means and methods for detecting methylated dna |
| 03/27/2008 | WO2004069200A3 Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases |
| 03/27/2008 | WO2003075845A3 Immunogenicity of glucan binding protein |
| 03/27/2008 | US20080076907 Enriching for cell surface proteins by oxidizing glycosylated protein with periodate, incubate with binding complex, recover proteins |
| 03/27/2008 | US20080076906 Antagonists of neuropilin receptor function and use thereof |
| 03/27/2008 | US20080076904 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/27/2008 | US20080076732 Gene expression control DNA element and associated protein |
| 03/27/2008 | US20080076716 Anti-Microbial Defensin-Related Peptides and Methods of Use |
| 03/27/2008 | US20080076715 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 03/27/2008 | US20080076713 Peptides selectively lethal to malignant and transformed mammalian cells |
| 03/27/2008 | US20080076712 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/27/2008 | US20080076710 covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides treating Hepatitis-C virus |
| 03/27/2008 | US20080076709 Isolated polypeptide, encoded by nucleic acid sequence, a vector from Staphylococcus; use for activators or inhibitors in therapy, antigen for vaccination, antibodies; antibacterial agent treating Staphylococcus infections; biodrugs |
| 03/27/2008 | US20080076708 Active Variants of the Il-18 Binding Protein and Medical Uses Thereof |
| 03/27/2008 | US20080076705 Antidiabetic agents; genetic engineered polypeptide; having a side chain attached alpha -amino group of the N-terminal amino acid of the B chain via an amide bond, with free carboxylic acid group, a fatty acid; soluble at physiological pH, prolonged profile of action; hypoglycemic agents |
| 03/27/2008 | US20080076701 double stranded ribonucleic acid is conjugated to the peptide; interfering ribonucleic acid with a delivery peptide; biodrug treating influenza in animal, inflammation occurs in arthritis, psoriasis |
| 03/27/2008 | US20080076673 Engineered binding proteins |
| 03/27/2008 | US20080076671 Applications of Nucleic Acid Fragments |
| 03/27/2008 | US20080076669 Method of screening by using conformation sensitive peptides |
| 03/27/2008 | US20080076183 Macromolecular conjugate which comprises alanine, glycine and argine in c-terminal domain for use coagulation diagnostics |
| 03/27/2008 | US20080076179 Sugar and lipid metabolism regulators in plants |
| 03/27/2008 | US20080076175 Generating transgenic lymphoid cell comprising sequences coding immunoglobulin epitope for use in tissue targeted therapies |
| 03/27/2008 | US20080076161 Using expression vector comprising nucleotide sequences coding malaria antigen (LSA-NRC) and/or protein synthesis complex (MCP) to transform bacterial host and propagate preferential polypeptides |
| 03/27/2008 | US20080076156 Process for production of recombinant proteins as a soluble form |
| 03/27/2008 | US20080076151 Compositions for controlling hair growth |
| 03/27/2008 | US20080076150 Isolating preferential protein from tissue extract using acidic washes and centrifugation |
| 03/27/2008 | US20080076136 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement |
| 03/27/2008 | US20080075782 Comprising a stabilizing polyol and a bioactive agent, wherein the composition provides quick release of the bioactive agent after administration; inhalation through the mouth; drug delivery; osteoporosis treatment |